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Stimulation of V(D)J recombination by histone acetylation
Fraser McBlane* and Joan Boyes†
V(D)J recombination assembles functional
immunoglobulin and T cell receptor genes from
individual gene segments [1]. A common recombination
mechanism, initiated by the proteins RAG1 and RAG2 at
conserved recombination signal sequences (RSSs),
operates at all rearranging loci [2,3]. It has been
proposed that the key regulator of the reaction is
‘accessibility’ of the RSS within chromatin [4]. Recently,
the packaging of RSSs into nucleosomes was shown to
inhibit initiation of V(D)J recombination [5,6].
Nevertheless, the tight tissue specificity of regulation
cannot be explained by nucleosome-mediated
repression alone because a significant fraction of RSSs
would be predicted to lie in linker regions between
nucleosomes. Therefore, some aspect of the regulation
of the recombination reaction must rely on the disruption
of higher-order chromatin structure. Here, we report that
histone acetylation directly stimulates the recombination
reaction in vivo in the correct cell- and stage-specific
manner. Neither expression of RAG genes nor activity of
RAG proteins was increased by acetylation. Furthermore,
histone acetylation failed to overcome nucleosome-
mediated repression of RSS recognition and cleavage
in vitro. Our data suggest a role for histone acetylation in
stimulating recombination in vivo through disruption of
higher-order chromatin structures.
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Results and discussion
Determining how a chromatin structure that is compatible
with V(D)J recombination is generated is a fundamental
problem. Loci undergoing recombination have been corre-
lated with increased DNase I sensitivity [4,7], demethyla-
tion [8] and sterile transcription [9]. Recently, a causal link
between increased DNase I sensitivity and histone acety-
lation was demonstrated [10], suggesting that loci under-
going recombination might also be hyperacetylated. In
addition, biochemical studies have suggested that histone
acetylation can destabilise the 30 nm structure [11]. 
To investigate the effect of histone acetylation on V(D)J
recombination in vivo, we incubated the transformed pre-
B cell line 103/BCL-2 with the histone deacetylase
inhibitor, trichostatin A (TSA). Following incubation,
genomic DNA was prepared and immunoglobulin VJκ1
rearrangement assayed by PCR. As a positive control,
VJκ1 rearrangements were induced in 103/BCL-2 cells by
heat shock [12]. As can be seen in Figure 1a, VJκ1 recom-
bination was activated in TSA-treated cells. This was not
due to increased expression of the RAG genes, as assayed
by reverse transcription (RT)–PCR (Figure 2a) nor
increased levels of RAG proteins (Figure 2b). Moreover,
the level of activity of the RAG proteins was unchanged
within TSA-treated 103/BCL-2 cells: V(D)J recombina-
tion on plasmid substrates was equivalent in transfected
cells incubated either with or without TSA (Figure 2c). In
addition, incubation of RAG proteins in vitro with histone
acetyltransferases and acetylCoA did not increase RAG
activity (data not shown). The most likely explanation for
increased VJκ1 recombination is that increased histone
acetylation at the immunoglobulin κ locus generates
increased accessibility to RAG proteins already present in
Figure 1
Histone acetylation stimulates immunoglobulin κ recombination in
pre-B cells. (a) Genomic DNA was prepared from 103/BCL-2 pre-B
cells that were untreated (U; maintained at 34°C), subjected to heat
shock (HS; cultured at 39.5°C for 12 h), or cultured in a deacetylase
inhibitor (TSA; 500 ng/ml at 34°C for 12 h). VκJκ1 rearrangements
(0.25 kb) were assayed by PCR. DNA from a B cell hybridoma
(B) containing a VκJκ1 rearrangement was used as a control. Either
20 ng (odd-numbered lanes) or 100 ng substrate was amplified.
(b) The same 103/BCL-2 genomic DNA preparations were used to
assay for TCRβ rearrangements by PCR. Thymocyte DNA (T) was
used as a positive control. The positions of the 1.8 kb germ-line
(gl) Dβ2 product and the possible Dβ2Jβ2 products are shown.
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this cell line. This is consistent with the finding that TSA
treatment also increased accessibility of the immunoglob-
ulin κ locus to DNase I (Figure 2d).
The T cell receptor β (TCRβ) locus is in the germ-line
configuration in the 103/BCL-2 cell line. If histone acety-
lation is sufficient to increase chromatin accessibility to
RAG proteins at all rearranging loci, TCRβ rearrange-
ments should be detected following TSA treatment.
Therefore, we used the same genomic DNA samples in
which VJκ1 rearrangements were induced by histone
acetylation (Figure 1a) to look for DJβ rearrangement
products, the earliest rearrangement stage to occur at the
TCRβ locus [1]. No DJβ products were detected
(Figure 1b), and alterations in accessibility to DNase I
were less than at the immunoglobulin κ locus following
addition of TSA (Figure 2d). This indicates that additional
factors mediate and target increased locus accessibility
within recombinationally active lymphocytes.
To investigate how increased acetylation stimulates
recombination, we determined whether acetylation assists
RAG cleavage on nucleosome templates. Previously, using
positioned nucleosomes, reconstitution of RSSs into a
nucleosome was shown to repress initiation of recombina-
tion [5,6]. To investigate this phenomenon further, a
196 bp restriction fragment containing a functional 12-
spacer RSS was assembled into mononucleosomes. The
positions of the nucleosome along the 196 bp fragment
were mapped using micrococcal nuclease (see the Supple-
mentary material). In all positions, the RAG cleavage site
was bound by a nucleosome and no evidence for specific
nucleosome positioning by the RSS was found. 
Initiation of V(D)J recombination on these templates was
investigated by addition of purified RAG1 and RAG2,
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Figure 2
TSA increases locus accessibility without altering RAG activity.
(a) The amounts of RAG1 and RAG2 cDNAs were estimated by PCR
using cDNA samples prepared from untreated (U), heat-shocked (HS),
or TSA-treated 103/BCL-2 cells. A sample in which reverse
transcriptase was omitted (–RT) was used as a negative control; cDNA
from each sample was normalised by PCR using primers to the HPRT
gene. (b) Western blots were performed on whole cell extracts from
103/BCL-2 cells grown for 12 h with or without TSA. Separate blots
were hybridised with antibodies against RAG1 or RAG2, as indicated.
Equal loading was confirmed using an antibody against mammalian
SMC1 protein. (c) To determine the level of RAG activity, 1 µg plasmid
pGG52 was transfected into 3 × 106 103/BCL-2 cells using
lipofectamine. Following transfection, untreated cells were incubated for
48 h in tissue culture medium. For TSA treatment, transfected cells
were incubated for 12 h in medium containing 500 ng/ml TSA then for
36 h without TSA. (d) Nuclei were prepared from 8 × 107 103/BCL-2
cells, cultured with or without TSA, and incubated with the indicated
amounts of DNase I. Following DNase I digestion, genomic DNA was
digested with EcoRI plus BamHI, and 5 µg of each sample was
resolved on an agarose gel. Southern blotting was performed by
hybridisation with an immunoglobulin (Ig) κ probe (upper panels). The
filter was then stripped and re-probed with a TCRβ probe (lower
panels). In the absence of DNase I (0 units), some increased digestion
is seen at the immunoglobulin κ locus in the presence of TSA; we
suggest this is due to the action of endogenous nucleases, which will
have a greater accessibility at more open loci. The small increase in
DNase I accessibility at the TCRβ locus following TSA treatment was
insufficient to permit rearrangement; a similar change was seen at the
inactive pre-T α locus. These changes are consistent with effects of
TSA at inactive loci, which have been described previously.
Figure 3
Cleavage at an RSS by RAG1 and RAG2 is blocked by a nucleosome.
(a) A 196 bp fragment carrying a functional 12-spacer RSS was
reconstituted into a nucleosome by salt–urea dialysis. Free DNA (lanes
1,2) or nucleosomal substrate (lanes 3,4) was incubated with
50–150 ng purified RAG1 and RAG2 [3] for 60 min at 37°C and the
reaction products separated on a native acrylamide gel. Arrows
indicate the positions of nucleosome and free DNA substrates, and of
signal end (12-SE, 121 bp) and coding end (12-CE, 75 bp) cleavage
products. (b) The 192 bp 23-spacer RSS substrate was labelled at
the 3′ end on the signal side only; thus, only the signal end (23-SE)
RAG cleavage product is seen. (c) An aliquot of each of the reaction
products in (a) was analysed under denaturing conditions. The 75 bp
hairpin coding end now runs at 150 nucleotides; the signal end and
nicked signal products both run at 121 nucleotides. M, size marker.
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which introduce a DNA double-strand break (DSB) at the
border of the RSS [3,13]. Generation of a DSB and the
integrity of nucleosomes following incubation was
analysed by native gel electrophoresis (Figure 3a). Using a
free DNA template, the expected products (121 bp signal
end, and 75 bp coding end) were generated. In contrast,
with mononucleosome templates, formation of DSBs was
almost undetectable. Consistent with previous results,
these data show that a nucleosome blocks initiation of
recombination. Similarly, packaging the 23-spacer mouse
immunoglobulin κ locus Jκ1 RSS into a nucleosome also
severely inhibited RAG-mediated signal cleavage (by
more than 60-fold; Figure 3b). 
It remained possible that the signal had been cleaved on
the nucleosome but the products were not released. More-
over, nicked products would not be separated from sub-
strate under the native gel conditions used above. RAG
cleavage reactions were therefore analysed under denatur-
ing conditions. No additional cleavage products were
observed (Figure 3c). This demonstrates that the initial
nicking step and, therefore, the subsequent formation of
DSBs is blocked by the presence of a nucleosome.
RAG1 and RAG2 bind directly to the signal sequences and
form specific cleavage-reaction complexes [14]. Using gel
retardation analysis, we determined whether nucleosome-
mediated inhibition of signal cleavage could be explained
by the inability of RAG1 and RAG2 to bind to nucleosome
templates. To eliminate non-specific binding of RAG1 and
RAG2 to DNA outside the 146 bp nucleosome core, a
150 bp fragment with the RSS cutting site 90 bp from the
end was reconstituted into a nucleosome. A RAG-depen-
dent binding product was only detectable with free DNA
templates (Figure 4a). No additional binding products
were seen with nucleosome substrate although binding to
free DNA was uninhibited by the presence of nucleosomes
(lane 6). Thus, inhibition of RAG cleavage by nucleosomes
is at the level of RAG binding.
To determine whether acetylation stimulates recombina-
tion in vivo by overcoming the nucleosome-mediated
repression, we next determined whether acetylation of the
histone tails also permitted RAG cutting on nucleosome
templates. Using hyperacetylated histones prepared from
TSA-treated CV-1 fibroblasts, nucleosomes were reconsti-
tuted and RAG cutting was analysed as above. No stimula-
tion of cutting was observed (Figure 4b). The same result
was obtained using hyperacetylated histones prepared from
the 103/BCL-2 pre-B cell line (data not shown). It is possi-
ble that the acetylated histones from CV1 fibroblasts do not
have the correct pattern of acetylation. We therefore acety-
lated reconstituted nucleosomes with p300, which is known
to have the broadest specificity of lysines acetylated [15].
Again, no stimulation of cutting was observed (data not
shown). Finally, to increase the number of sites modified,
we further acetylated nucleosomes reconstituted with
acetylated histones using the acetyltransferases p300 and
PCAF. Again, no stimulation of cutting was observed. This
suggests that acetylation cannot overcome the nucleosome-
mediated repression of recombination. 
We have shown here that increased histone acetylation
stimulates V(D)J recombination in vivo in the correct cell-
and locus-specific manner. As acetylation of nucleosome
templates in vitro failed to overcome the nucleosome-
mediated repression of recombination, the most likely
explanation for the effects in vivo is that acetylation




(a) Preferential binding of RAGs to free DNA
substrates. A 150 bp 12-spacer RSS
substrate was reconstituted into a
nucleosome. Substrates were incubated with
RAG1 and RAG2 for 30 min at room
temperature and the products analysed under
native gel conditions; under these conditions,
DNA binding occurs but cleavage is very
inefficient. The position of a RAG–DNA
binding complex (lane 2) is indicated. No
additional binding products were seen with a
nucleosomal substrate (lane 4). Addition of
extra free DNA to nucleosomal substrate
showed that nucleosomes do not inhibit the
ability of RAGs to bind to an accessible
substrate (lane 6). (b) Histone acetylation
does not facilitate RAG cutting on
nucleosome templates. Free DNA,
nucleosome, or hyperacetylated nucleosome
substrates containing a 150 bp 12-spacer
RSS fragment were incubated with RAG1
and RAG2. Reaction products (90 bp signal
end and 60 bp coding end) were resolved
under native conditions. 
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Acetylation alone is probably insufficient to generate the
structure compatible with recombination. Other features
that have been linked to recombination include increased
general DNase I sensitivity, demethylation and sterile
transcription [7–9]. Our data ties in well with these other
observed changes: increased generalised DNase I sensitiv-
ity has been linked to increased histone acetylation [10]
and we have shown here that DNase I accessibility is pref-
erentially increased at the immunoglobulin κ locus follow-
ing TSA treatment. Additionally, methylated DNA is
bound by methylated DNA-binding proteins, which assist
in keeping the associated DNA inaccessible [16]. One of
these methylated DNA-binding proteins, MeCP-2, is
associated with a deacetylase complex [17]. Demethyla-
tion of a region undergoing recombination could thus
facilitate decreased deacetylation of the locus.
A key question is how the histone acetyltransferases are
specifically targeted to recombining loci. Enhancers of
recombination have been shown to be central in stimulat-
ing recombination. These enhancers could function by a
number of different mechanisms. Firstly, some enhancers
stimulate sterile transcription [18]. As the acetyltrans-
ferase PCAF is associated with elongating RNA poly-
merase II [19], sterile transcription through a locus before
recombination could promote increased acetylation. Sec-
ondly, in vivo footprinting of the immunoglobulin κ locus  3′
enhancer has shown that the transcription factors occupying
the enhancer differ in pro-B cells and in pre-B cells [20]. In
the latter, where the immunoglobulin κ locus has gained
the potential to undergo recombination, the transcription
factor CREB is recruited. The coactivator of CREB is CBP,
which has potent acetyltransferase activity [15]. Finally, the
immunoglobulin κ locus intronic enhancer has been impli-
cated in promoting locus demethylation [21]. The conse-
quent loss of MeCP-2 and associated deacetylase complex
could thus further enhance locus acetylation.
Taken together, our data suggest a model whereby tran-
scription factors at enhancers of recombination can lead,
either directly or indirectly, to recruitment of acetyl-
transferases or loss of deacetylases. Increased acetylation of
a locus helps to generate a more ‘accessible’ chromatin
structure. This could facilitate either direct RAG accessibil-
ity or accessibility to nucleosome disrupters which, in turn,
permit RAG cutting.
Supplementary material
Additional methodological detail and a figure showing the positions of
nucleosomes reconstituted onto a fragment containing a 12-spacer RSS
are available at http://current-biology.com/supmat/supmatin.htm.
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